Values First Advisors Inc. acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the 4th quarter, Holdings Channel.com reports. The institutional investor acquired 317 shares of the financial services provider’s stock, valued at approximately $43,000.
Several other institutional investors and hedge funds also recently made changes to their positions in IBB. Good Life Advisors LLC bought a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at about $217,000. WealthCare Investment Partners LLC increased its stake in iShares Biotechnology ETF by 3.9% in the 4th quarter. WealthCare Investment Partners LLC now owns 9,043 shares of the financial services provider’s stock worth $1,261,000 after purchasing an additional 343 shares in the last quarter. WASHINGTON TRUST Co increased its stake in iShares Biotechnology ETF by 212.0% in the 4th quarter. WASHINGTON TRUST Co now owns 596 shares of the financial services provider’s stock worth $81,000 after purchasing an additional 405 shares in the last quarter. First National Corp MA ADV increased its stake in iShares Biotechnology ETF by 6.9% in the 4th quarter. First National Corp MA ADV now owns 15,159 shares of the financial services provider’s stock worth $2,059,000 after purchasing an additional 978 shares in the last quarter. Finally, PFG Investments LLC grew its stake in iShares Biotechnology ETF by 118.4% during the 4th quarter. PFG Investments LLC now owns 4,397 shares of the financial services provider’s stock valued at $597,000 after acquiring an additional 2,384 shares in the last quarter. 62.45% of the stock is currently owned by hedge funds and other institutional investors.
iShares Biotechnology ETF Trading Down 0.4 %
Shares of NASDAQ IBB traded down $0.57 during trading hours on Thursday, hitting $137.22. The stock had a trading volume of 1,441,164 shares, compared to its average volume of 1,868,127. The firm’s 50-day moving average price is $136.42 and its two-hundred day moving average price is $128.75. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $141.16.
iShares Biotechnology ETF Dividend Announcement
iShares Biotechnology ETF Company Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
See Also
- Five stocks we like better than iShares Biotechnology ETF
- Stock Market Upgrades: What Are They?
- 3 Value Stocks Too Small For Buffett’s Portfolio
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- The Most Important Warren Buffett Stock for Investors: His Own
- Disney Stock Catches 3 Upgrades In a Single Week
Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBB – Free Report).
Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.